James A. Geraghty

James Geraghty was appointed a member of our Board of Directors and Chair of the Board in July 2013, a position he held until April 2021. Mr. Geraghty is an industry leader with over 35 years of strategic and leadership experience, including more than 25 years as a senior member of executive teams at biotechnology companies developing and commercializing innovative therapies. Mr. Geraghty previously was an Entrepreneur in Residence at Third Rock Ventures, a leading biotech venture fund, from 2013 to 2016, and served as a Senior Vice President of Sanofi S.A., a global healthcare company from 2011 to 2012. Prior to that, he served in various senior management roles at Genzyme Corporation, or Genzyme, a biotechnology company, including as Senior Vice President, International Development and President of Genzyme Europe. Mr. Geraghty currently serves as chairman of the boards of Orchard Therapeutics and Pieris Pharmaceuticals and as a member of the boards of Voyager Therapeutics and Fulcrum Therapeutics. He also previously served as a director of bluebird bio and GTC Biotherapeutics.

Mr. Geraghty holds a J.D. from the Yale Law School, a Master of Science from the University of Pennsylvania, and a Bachelor of Arts degree from Georgetown University.